| Entry |
|
|---|
| Name |
Pegozafermin (USAN) |
|---|
| Formula |
C868H1351N239O263S4. C19H34N2O15. C2nH4n+2On+1
|
|---|
| Sequence |
MHPIPDSSPL LQFGGQVRQR YLYTDDAQQT EAHLEIREDG TVGGAADQSP ESLLQLKALK
PGVIQILGVK TSRFLCQRPD GALYGSLHFD PEACSFRELL LEDGYNVYQS EAHGLPLHLP
GNKSPHRDPA PRGPARFLPL PGLPPALPEP PGILAPQPPD VGSSDPLSMV GPTQGASPSY
AS
(Disulfide bridge: 76-94) |
|---|
| Type |
Peptide |
|---|
| Efficacy |
Fibroblast growth factor replacement |
|---|
| Comment |
Treatment of nonalcoholic steatohepatitis and severe hypertriglyceridemia
|
|---|
| Target |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Signaling molecules and receptors
Cytokines
Growth factors (RTK-binding)
FGF21
D12327 Pegozafermin (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
